MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Omnicell Inc

Fechado

SetorSaúde

50.76 0.42

Visão Geral

Variação de preço das ações

24h

Atual

Mín

49.79

Máximo

51.25

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

109.14

87.826

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+7.14% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

753M

2.2B

Abertura anterior

50.34

Fecho anterior

50.76

Sentimento de Notícias

By Acuity

50%

50%

187 / 370 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de jan. de 2026, 22:18 UTC

Conversa de Mercado

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 de jan. de 2026, 21:43 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 de jan. de 2026, 20:39 UTC

Conversa de Mercado

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 de jan. de 2026, 20:38 UTC

Conversa de Mercado

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 de jan. de 2026, 20:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 de jan. de 2026, 20:30 UTC

Conversa de Mercado

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 de jan. de 2026, 20:15 UTC

Conversa de Mercado

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 de jan. de 2026, 20:07 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de jan. de 2026, 20:07 UTC

Conversa de Mercado

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 de jan. de 2026, 19:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 de jan. de 2026, 19:42 UTC

Conversa de Mercado

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 de jan. de 2026, 19:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Wolters Kluwer Acquires StandardFusion >WTKWY

9 de jan. de 2026, 19:31 UTC

Ganhos

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 de jan. de 2026, 19:28 UTC

Ganhos

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 de jan. de 2026, 18:30 UTC

Conversa de Mercado

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 de jan. de 2026, 18:23 UTC

Conversa de Mercado

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

9 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jan. de 2026, 17:19 UTC

Conversa de Mercado

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de jan. de 2026, 17:07 UTC

Conversa de Mercado

McDonald's Promotions Appear Successful -- Market Talk

9 de jan. de 2026, 17:06 UTC

Conversa de Mercado

Oil Futures on Track for Weekly Gains -- Market Talk

9 de jan. de 2026, 17:05 UTC

Ganhos

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9 de jan. de 2026, 16:57 UTC

Conversa de Mercado

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9 de jan. de 2026, 16:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jan. de 2026, 16:46 UTC

Conversa de Mercado

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

7.14% parte superior

Previsão para 12 meses

Média 54.2 USD  7.14%

Máximo 63 USD

Mínimo 46 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

187 / 370 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat